Abstract
-
Background
- Detection of antibodies to extractable nuclear antigens (ENAs) is needed for the diagnosis in systemic autoimmune diseases. In this study, we compared three reagents using line immunoblot assay (LIA) or multiplex bead immunoassay for detecting the anti-ENAs.
-
Methods
- A total of 89 sera were tested by 3 different assays: EUROASSAY Anti-ENA Profile (Euroimmune, Germany), Polycheck Autoimmune Test (Biocheck GmbH, Germany), and FIDIS™ Connective Profile (Biomedical Diagnostics, France). The following individual ENAs were investigated: Sm, SS-A (Ro), SS-B (La), Scl-70, Jo-1 and RNP. We reviewed medical records to investigate the discrepant results among three methods.
-
Results
- Overall percent agreements were 96.1% between EUROASSAY Anti-ENA Profile and FIDIS™ Connective profile; 90.4% between EUROASSAY Anti-ENA Profile and Polycheck Autoimmune Test using the manufacturers’ cutoff; 96.4% between EUROASSAY Anti-ENA Profile and Polycheck Autoimmune Test using a upward cutoff; 90.4% between FIDIS™ Connective profile and Polycheck Autoimmune Test the manufacturers’ cutoff; and 96.4% between FIDIS™ Connective profile and Polycheck Autoimmune Test a upward cutoff.
-
Conclusions
- The three assays showed excellent agreement with each other. With appropriate cutoff, the all three assays for six of the anti-ENA tests investigated in this study can be used in clinical laboratories for detecting the anti-ENAs.
-
Keywords: Anti-extractable nuclear antigen antibodies; Antinuclear antibodies; Autoimmunity
Table 1.Comparison of the results for antibodies to extractable nuclear antigens by EUROASSAY Anti-ENA Profile and Polycheck Autoimmune Test (N = 89)
Cutoff of Polycheck Autoimmune Test = grade 1 |
Antigen |
Concordant results |
Discrepant results |
Concordance rate (%) |
Kappa coefficient (95% CI) |
P-value |
EUROASSAY-/ Polycheck- |
EUROASSAY+/ Polycheck+ |
EUROASSAY-/ Polycheck+ |
EUROASSAY+/ Polycheck- |
Sm |
74 |
1 |
14 |
0 |
84.3 |
0.11 (-0.32-0.53) |
0.027 |
SSA |
57 |
22 |
8 |
2 |
88.8 |
0.74 (0.58-0.89) |
0.000 |
SSB |
67 |
5 |
17 |
0 |
80.9 |
0.31 (0.01-0.60) |
0.000 |
scl-70 |
80 |
4 |
5 |
0 |
94.4 |
0.59 (0.24-0.94) |
0.000 |
Jo-1 |
86 |
0 |
2 |
1 |
96.6 |
N/A |
N/A |
nRNP |
83 |
2 |
0 |
4 |
95.5 |
0.48 (-0.01-0.98) |
0.000 |
Cutoff of Polycheck Autoimmune Test = grade 2 |
Antigen |
Concordant results |
Discrepant results |
Concordance rate (%) |
Kappa coefficient (95% CI) |
P-value |
EUROASSAY-/ Polycheck- |
EUROASSAY+/ Polycheck+ |
EUROASSAY-/ Polycheck+ |
EUROASSAY+/ Polycheck- |
Sm |
85 |
1 |
3 |
0 |
96.6 |
0.39 (-0.29-1.07) |
0.000 |
SSA |
64 |
21 |
1 |
3 |
95.5 |
0.88 (0.77-0.99) |
0.000 |
SSB |
77 |
4 |
7 |
1 |
91.0 |
0.46 (0.10-0.82) |
0.000 |
scl-70 |
84 |
4 |
1 |
0 |
98.9 |
0.88 (0.66-1.11) |
0.000 |
Jo-1 |
88 |
0 |
0 |
1 |
98.9 |
N/A |
N/A |
nRNP |
83 |
2 |
0 |
4 |
95.5 |
0.48 (-0.01-0.98) |
0.000 |
Table 2.Comparison of the results for antibodies to extractable nuclear antigens by EUROASSAY Anti-ENA Profile and FIDIS Connective Profile (N = 89)
Antigen |
Concordant results |
Discrepant results |
Concordance rate (%) |
Kappa coefficient (95% CI) |
P-value |
EUROASSAY-/ FIDIS |
EUROASSAY+/ FIDIS+ |
EUROASSAY-/ FIDIS+ |
EUROASSAY+/ FIDIS- |
Sm |
85 |
1 |
0 |
3 |
96.6 |
0.39 (-0.29-1.07) |
0.000 |
SSA |
61 |
19 |
6 |
3 |
89.9 |
0.74 (0.58-0.90) |
0.000 |
SSB |
80 |
5 |
4 |
0 |
95.5 |
0.69 (0.40-0.99) |
0.000 |
scl-70 |
84 |
4 |
1 |
0 |
98.9 |
0.88 (0.66-1.11) |
0.000 |
Jo-1 |
88 |
0 |
0 |
1 |
98.9 |
N/A |
N/A |
RNP |
83 |
3 |
0 |
3 |
96.6 |
0.65 (0.26-1.04) |
0.000 |
Table 3.Comparison of the results for antibodies to extractable nuclear antigens by Polycheck Autoimmune Test FIDIS Connective Profile (N = 89)
Cutoff of Polycheck Autoimmune Test = grade 1 |
Antigen |
Concordant results |
Discrepant results |
Concordance rate (%) |
Kappa coefficient (95% CI) |
P-value |
Polycheck-/ FIDIS- |
Polycheck+/ FIDIS+ |
Polycheck-/ FIDIS- |
Polycheck+/ FIDIS+ |
Sm |
74 |
1 |
0 |
14 |
84.3 |
0.11 (-0.32-0.54) |
0.026 |
SSA |
57 |
19 |
2 |
11 |
85.4 |
0.65 (0.47-0.82) |
0.000 |
SSB |
66 |
8 |
1 |
14 |
83.1 |
0.44 (0.17-0.70) |
0.000 |
scl-70 |
79 |
4 |
1 |
5 |
93.3 |
0.54 (0.18-0.90) |
0.000 |
Jo-1 |
87 |
0 |
0 |
2 |
97.8 |
N/A |
N/A |
nRNP |
86 |
2 |
1 |
0 |
98.9 |
0.79 (0.40-1.20) |
0.000 |
Cutoff of Polycheck Autoimmune Test = grade 2 |
Antigen |
Concordant results |
Discrepant results |
Concordance rate (%) |
Kappa coefficient (95% CI) |
P-value |
Polycheck-/ FIDIS- |
Polycheck+/ FIDIS+ |
Polycheck-/ FIDIS- |
Polycheck+/ FIDIS+ |
Sm |
85 |
1 |
3 |
0 |
96.6 |
0.39 (-0.29-1.07) |
0.000 |
SSA |
64 |
21 |
1 |
3 |
92.1 |
0.79 (0.63-0.94) |
0.000 |
SSB |
77 |
4 |
7 |
1 |
93.3 |
0.66 (0.40-0.92) |
0.000 |
scl-70 |
84 |
4 |
1 |
0 |
97.8 |
0.79 (0.50-1.08) |
0.000 |
Jo-1 |
88 |
0 |
0 |
1 |
100.0 |
N/A |
N/A |
nRNP |
83 |
2 |
0 |
4 |
98.9 |
0.79 (0.39-1.20) |
0.000 |
Table 4.Comparison of the results for antibodies to extractable nuclear antigens by EUROASSAY Anti-ENA Profile and FIDIS Connective profile in the systemic autoimmune disorder (n = 33).
Antigen |
Concordant results |
Discrepant results |
Concordance rate (%) |
Kappa coefficient (95% CI) |
P-value |
EUROASSAY-/ FIDIS |
EUROASSAY+/ FIDIS+ |
EUROASSAY-/ FIDIS+ |
EUROASSAY+/ FIDIS- |
Sm |
32 |
1 |
0 |
0 |
100.0 |
1.00 (1.00-1.00) |
0.000 |
SSA |
16 |
15 |
0 |
2 |
93.9 |
0.88 (0.72-1.04) |
0.000 |
SSB |
27 |
4 |
2 |
0 |
93.9 |
0.77 (0.45-1.08) |
0.000 |
scl-70 |
30 |
3 |
0 |
0 |
100.0 |
1.00 (1.00-1.00) |
0.000 |
Jo-1 |
33 |
0 |
0 |
0 |
100.0 |
N/A |
N/A |
RNP |
29 |
2 |
0 |
2 |
93.9 |
0.64 (0.15-1.12) |
0.000 |
References
- 1.The Korean Society for Laboratory Medicine. Laboratory Medicine. 5 ed 2014.
- 2.Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 2000;124:71–81.ArticlePubMed
- 3.Bossuyt X, Luyckx A. Antibodies to extractable nuclear antigens in antinuclear antibody–negative samples. Clin Chem 2005;51:2426–7.ArticlePubMed
- 4.Hoffman IE, Peene I, Veys EM, De Keyser F. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. Clinical chem 2002;48:2171–6.Article
- 5.López-Longo FJ, Rodríguez-Mahou M, Escalona-Monge M, González CM, Monteagudo I, Carreño-Pérez L. Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system. Lupus 2003;12:623–9.ArticlePubMed
- 6.Delpech A, Gilbert D, Daliphard S, Le Loet X, Godin M, Tron F. Antibodies to Sm, RNP and SSB detected by solid–phase ELISAs using recombinant antigens: A comparison study with counter immunoelectrophoresis and immunoblotting. J Clin Lab Anal 1993;7:197–202.ArticlePubMed
- 7.Martins TB, Burlingame R, von Mühlen CA, Jaskowski TD, Litwin CM, Hill HR. Evaluation of multiplexed fluorescent microsphere immuno- assay for detection of autoantibodies to nuclear antigens. Clin Diagn Lab Immunol 2004;11:1054–9.ArticlePubMedPMCPDF
- 8.Kim JM, Ihm CH, Sin DH, Ihm MK, Sim SC. Detection of anti-ENA and anti-dsDNA antibodies using line immunoassay in systemic autoimmune diseases. Korean J Lab Med 2008;28:353–61.ArticlePubMed
- 9.Rouquette AM, Desgruelles C, Laroche P. Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods. Am J Clin Pathol 2003;120:676–81.ArticlePubMed
- 10.Rouquette AM, Desgruelles C. Detection of antibodies to dsDNA: an overview of laboratory assays. Lupus 2006;15:403–7.ArticlePubMed
- 11.Johnson S, Goek O, Singh-Grewal D, Vlad S, Feldman B, Felson D, et al. Classification criteria in rheumatic diseases: a review of methodologic properties. Arthritis Rheum 2007;57:1119–33.ArticlePubMed
- 12.Altman DG. Practical statistics for medical research: CRC press 1990.
- 13.James K, Meek G. Evaluation of commercial enzyme immunoassays compared to immunofluorescence and double diffusion for autoantibodies associated with autoimmune diseases. Am J Clin Pathol 1992;97:559–65.ArticlePubMed
- 14.Damoiseaux J, Boesten K, Giesen J, Austen J, Tervaert JW. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Ann N Y Acad Sci 2005;1050:340–7.ArticlePubMed
- 15.Vercammen M, Meirlaen P, Sennesael J, Velkeniers B, T'Kint S, Verbruggen L, et al. Diagnostic accuracy of the FIDIS multiplex fluorescent microsphere immunodetection system for anti-extractable nuclear antigen (ENA) antibodies in connective tissue diseases. Clin Chem Lab Med 2007;45:505–12.ArticlePubMed
Citations
Citations to this article as recorded by